Pharmacyclics, Inc. Stock
Equities
US7169331060
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
2015 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 15-04-30 | |
Betty Chang
CTO | Chief Tech/Sci/R&D Officer | - | 13-07-08 |
Alvina Chu
PRN | Corporate Officer/Principal | - | - |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- Stock